Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

Part of paid clinical trials in Aliso Viejo, California.

Sponsor
AbbVie
Study ID
NCT07310290
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Migraine is a neurological disease characterized by moderate or severe headaches, associated with nausea, vomiting, and/or sensitivity to light and sound. This study will assess changes in migraine attack severity for adult participants treating with oral ubrogepant across migraine attacks. Ubrogepant is a drug that is approved for the acute treatment of migraine in adults. Approximately 189 participants will be enrolled in approximately 15 sites across the US. Participants will receive ubrogepant as prescribed by their physician according to their routine clinical practice and local label. Participants will be followed for up to 13 weeks. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.

Key Dates

Start date
Jan 27, 2026
Status verified
Feb 2026
Primary completion
Mar 31, 2027
Completion
Mar 31, 2027

Study Design

Enrollment
189 participants (estimated)

Arms

  • Arm: Ubrogepant
    Participants will receive Ubrogepant as prescribed by their physician according to local label.

Primary Outcome Measure

Percentage of Participants with Absence of moderate to severe headache over 24 hours post-dose during prodrome. [ Time Frame: Up to approximately 13 weeks ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Neurology and Pain Specialty Center /ID# 278508Aliso ViejoCalifornia92656-
Chicago Headache Center & Research Inst /ID# 272345NapervilleIllinois60563-
Tri City Research Center, LLC /ID# 278800Grand IslandNebraska68803-

Find similar trials in Aliso Viejo, CA

By condition
Migraine
By specialty
Neurology
By research site
Neurology and Pain Specialty Center· Aliso Viejo, CAChicago Headache Center & Research Inst· Naperville, ILTri City Research Center, LLC· Grand Island, NE

Related Studies